Status:
COMPLETED
Ropivacaine Pharmacokinetics in ESP Blocks
Lead Sponsor:
Thomas Jefferson University
Conditions:
Local Anesthetic Systemic Toxicity
Pain
Eligibility:
All Genders
18+ years
Brief Summary
This is a pharmacokinetic study to determine risk of local anesthetic systemic toxicity of ropivacaine when used in erector spinae plane blocks for thoracic surgery. Through serial blood sampling and ...
Detailed Description
The erector spinae plane (ESP) block was first described in 2016 as a novel fascial plane block that provided analgesia for thoracic neuropathic pain. Since then hundreds of articles have been publish...
Eligibility Criteria
Inclusion
- undergoing robotic or video-assisted thoracic surgery
- able to speak English
Exclusion
- active liver disease
- active renal disease
- ropivacaine allergy
Key Trial Info
Start Date :
March 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 23 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04807504
Start Date
March 26 2021
End Date
September 23 2021
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107